Skip to main content
. 2023 Jun 5;10:1186574. doi: 10.3389/fcvm.2023.1186574

Figure 2.

Figure 2

Doppler-derived coronary flow velocity. At the end of the injection, APV was higher in vehicle injected animals (with and without MI), as compared to hUCM-MSC (26.8 ± 6.8 vs. 20.5 ± 4.5; ANOVA p = 0.03). In infarcted animals injected with hUCM-MSC, final APV did not decrease significantly as compared do baseline (20.3 ± 4.5 vs. 21.5 ± 3.6; Related samples Wilcoxon Signed rank test p = 0.25). Symbols represent geometric means and bars represent standard deviation. APV, average peak velocity; T1/2—half time injection.